Hypoxia in the eye: A two-sided coin

High Altitude Medicine and Biology

Volumn 13, Issue 3, 2012, Pages 169-175

  Grimm, Christian ^a   Willmann, Gabriel ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

erythropoietin; hypoxia inducible factor; ophthalmic changes

Indexed keywords

HYPOXIA INDUCIBLE FACTOR; OXYGEN; VASCULOTROPIN;

CONFERENCE PAPER; DIABETIC RETINOPATHY; EYE DEVELOPMENT; GLAUCOMA; HUMAN; HYPOXIA; NERVE CELL; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; PROTEIN FUNCTION; RETINA DISEASE; RETINA MACULA AGE RELATED DEGENERATION; RETROLENTAL FIBROPLASIA; TISSUE OXYGENATION;

ALTITUDE; ANOXIA; ERYTHROPOIETIN; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; OXYGEN; PARTIAL PRESSURE; RETINA; RETINAL DISEASES; RETINAL VESSELS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84866689485     PISSN: 15270297     EISSN: 15578682     Source Type: Journal    
DOI: 10.1089/ham.2012.1031     Document Type: Conference Paper

References (76)

1. Antonetti DA, Klein R, and Gardner TW. (2012). Diabetic retinopathy. N Engl J Med 366:1227-1239.
2. Arden GB and Sivaprasad S. (2011). Hypoxia and oxidative stress in the causation of diabetic retinopathy. Curr Diabetes Rev 7:291-304.
3. Bandello F, Cunha-Vaz J, Chong NV, Lang GE, Massin P, Mitchell P, Porta M, Prunte C, Schlingemann R, and Schmidt-Erfurth U. (2012). New approaches for the treatment of diabetic macular oedema: Recommendations by an expert panel. Eye (Lond) 26:485-493.
4. Bantignies F and Cavalli G. (2006). Cellular memory and dynamic regulation of polycomb group proteins. Curr Opin Cell Biol 18:275-283.
5. Barthelmes D, Bosch MM, Merz TM, Petrig BL, Truffer F, Bloch KE, Holmes TA, Cattin P, Hefti U, Sellner M, Sutter FK, Maggiorini M, and Landau K. (2011). Delayed appearance of high altitude retinal hemorrhages. PLoS One. 6:e11532.
6. Bosch MM, Barthelmes D, Merz TM, Bloch KE, Turk AJ, Hefti U, Sutter FK, Maggiorini M, Wirth MG, Schoch OD, and Landau K. (2008). High incidence of optic disc swelling at very high altitudes. Arch Ophthalmol 126:644-650. (Pubitemid 351679559)
7. Bosch MM, Merz TM, Barthelmes D, Petrig BL, Truffer F, Bloch KE, Turk A, Maggiorini M, Hess T, Schoch OD, Hefti U, Sutter FK, Pichler J, Huber A, and Landau K. (2009). New insights into ocular blood flow at very high altitudes. J Appl Physiol 106:454-460.
8. Caprara C and Grimm C. (2012). From oxygen to erythropoietin: Relevance of hypoxia for retinal development, health and disease. Prog Retin Eye Res 31:89-119.
9. Caprara C, Thiersch M, Lange C, Joly S, Samardzija M, and Grimm C. (2011). HIF1A is essential for the development of the intermediate plexus of the retinal vasculature. Invest Ophthalmol Vis Sci 52: 2109-2117.
10. Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H, Scholz D, Acker T, DiPalma T, Dewerchin M, Noel A, Stalmans I, Barra A, Blacher S, Vandendriessche T, Ponten A, Eriksson U, Plate KH, Foidart JM, Schaper W, Charnock-Jones DS, Hicklin DJ, Herbert JM, Collen D, and Persico MG. (2001). Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7:575-583.
11. Colombo ES, Menicucci G, McGuire PG, and Das A. (2007). Hepatocyte growth factor/scatter factor promotes retinal angiogenesis through increased urokinase expression. Invest Ophthalmol Vis Sci 48:1793-1800. (Pubitemid 351261367)
12. Ferris FL, 3rd, Davis MD, and Aiello LM. (1999). Treatment of diabetic retinopathy. N Engl J Med 341:667-678. (Pubitemid 29399047)
13. Fischer MD, Willmann G, Schatz A, Schommer K, Zhour A, Zrenner E, Bartz-Schmidt KU, and Gekeler F. (2012). Structural and functional changes of the human macula during acute exposure to high altitude. PLoS One 7:e36155.
14. Flammer J, Orgul S, Costa VP, Orzalesi N, Krieglstein GK, Serra LM, Renard JP, and Stefansson E. (2002). The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 21:359-393. (Pubitemid 34879080)
15. Frank RN. (2004). Diabetic retinopathy. N Engl J Med 350:48-58. (Pubitemid 38032183)
16. Frayser R, Houston CS, Bryan AC, Rennie ID, and Gray G. (1970). Retinal hemorrhage at high altitude. N Engl J Med 282:1183-1184.
17. Gehrs KM, Anderson DH, Johnson LV, and Hageman GS. (2006). Age-related macular degeneration: Emerging pathogenetic and therapeutic concepts. Ann Med 38:450-471. (Pubitemid 44767496)
18. Gilbert C, Rahi J, Eckstein M, O'Sullivan J, and Foster A. (1997). Retinopathy of prematurity in middle-income countries. Lancet 350:12-14.
19. Grimm C, Wenzel A, Groszer M, Mayser H, Seeliger M, Samardzija M, Bauer C, Gassmann M, and Reme CE. (2002). HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med 8:718-724. (Pubitemid 34778725)
20. Grimm C, Wenzel A, Stanescu D, Samardzija M, Hotop S, Groszer M, Naash M, Gassmann M, and Reme C. (2004). Constitutive overexpression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration. J Neurosci 24:5651-5658. (Pubitemid 38857219)
21. Haase VH, Glickman JN, Socolovsky M, and Jaenisch R. (2001). Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. Proc Natl Acad Sci USA 98:583-1588.
22. Hackett SF, Wiegand S, Yancopoulos G, and Campochiaro PA. (2002). Angiopoietin-2 plays an important role in retinal angiogenesis. J Cell Physiol 192:182-187. (Pubitemid 34747786)
23. Ho TY, Kao WF, Lee SM, Lin PK, Chen JJ, and Liu JH. (2011). High-altitude retinopathy after climbing Mount Aconcagua in a group of experienced climbers. Retina 31:1650-1655.
24. Inoue Y, Yanagi Y, Matsuura K, Takahashi H, Tamaki Y, and Araie M. (2007). Expression of hypoxia-inducible factor 1alpha and 2alpha in choroidal neovascular membranes associated with age-related macular degeneration. Br J Ophthalmol 91:1720-1721. (Pubitemid 350207415)
25. Kocur I and Resnikoff S. (2002). Visual impairment and blindness in Europe and their prevention. Br J Ophthalmol 86:716-722. (Pubitemid 34713152)
26. Kuiper EJ, Witmer AN, Klaassen I, Oliver N, Goldschmeding R, and Schlingemann RO. (2004). Differential expression of connective tissue growth factor in microglia and pericytes in the human diabetic retina. Br J Ophthalmol 88:1082-1087. (Pubitemid 39013155)
27. Kurihara T, Kubota Y, Ozawa Y, Takubo K, Noda K, Simon MC, Johnson RS, Suematsu M, Tsubota K, Ishida S, Goda N, Suda T, and Okano H. (2010). von Hippel-Lindau protein regulates transition from the fetal to the adult circulatory system in retina. Development 137:1563-1571.
28. Lange C, Caprara C, Tanimoto N, Beck S, Huber G, Samardzija M, Seeliger M, and Grimm C. (2011a). Retina-specific activation of a sustained hypoxia-like response leads to severe retinal degeneration and loss of vision. Neurobiol Dis 41:119-130.
29. Lange C, Heynen SR, Tanimoto N, Thiersch M, Le YZ, Meneau I, Seeliger MW, Samardzija M, Caprara C, and Grimm C. (2011b). Normoxic activation of hypoxia-inducible factors in photoreceptors provides transient protection against lightinduced retinal degeneration. Invest Ophthalmol Vis Sci 52:5872-5880.
30. Lara-Castillo N, Zandi S, Nakao S, Ito Y, Noda K, She H, Ahmed M, Frimmel S, Ablonczy Z, and Hafezi-Moghadam A. (2009). Atrial natriuretic peptide reduces vascular leakage and choroidal neovascularization. Am J Pathol 175:2343-2350.
31. Lee JW, Bae SH, Jeong JW, Kim SH, and Kim KW. (2004). Hypoxia-inducible factor (HIF-1)alpha: Its protein stability and biological functions. Exp Mol Med 36:1-12.
32. Lima e Silva R, Shen J, Hackett SF, Kachi S, Akiyama H, Kiuchi K, Yokoi K, Hatara MC, Lauer T, Aslam S, Gong YY, Xiao WH, Khu NH, Thut C, and Campochiaro PA. (2007). The SDF-1/CXCR4 ligand/receptor pair is an important contributor to several types of ocular neovascularization. FASEB J 21:3219-3230. (Pubitemid 47565540)
33. Maslim J, Valter K, Egensperger R, Hollander H, and Stone J. (1997). Tissue oxygen during a critical developmental period controls the death and survival of photoreceptors. Invest Ophthalmol Vis Sci 38:1667-1677. (Pubitemid 27382332)
34. McNulty R, Wang H, Mathias RT, Ortwerth BJ, Truscott RJ, and Bassnett S. (2004). Regulation of tissue oxygen levels in the mammalian lens. J Physiol 559:883-898. (Pubitemid 39276176)
35. Mervin K and Stone J. (2002). Regulation by oxygen of photoreceptor death in the developing and adult C57BL/6J mouse. Exp Eye Res. 75:715-722. (Pubitemid 36034636)
36. Mintz-Hittner HA and Kuffel RR, Jr. (2008). Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. Retina 28:831-838.
37. Mintz-Hittner HA and Best LM. (2009). Antivascular endothelial growth factor for retinopathy of prematurity. Curr Opin Pediatr 21:182-187.
38. Morris DS, Severn PS, Smith J, Somner JE, Stannard KP, and Cottrell DG. (2007). High altitude and retinal detachment. High Alt Med Biol 8:337-339. (Pubitemid 350274417)
39. Noma H, Funatsu H, Yamashita H, Kitano S, Mishima HK, and Hori S. (2002). Regulation of angiogenesis in diabetic retinopathy: Possible balance between vascular endothelial growth factor and endostatin. Arch Ophthalmol 120:1075-1080. (Pubitemid 34856076)
40. Okawa H, Sampath AP, Laughlin SB, and Fain GL. (2008). ATP consumption by mammalian rod photoreceptors in darkness and in light. Curr Biol 18:1917-1921.
41. Osborne NN, Melena J, Chidlow G, and Wood JP. (2001). A hypothesis to explain ganglion cell death caused by vascular insults at the optic nerve head: Possible implication for the treatment of glaucoma. Br J Ophthalmol 85:1252-1259. (Pubitemid 32929554)
42. Pavlidis M, Stupp T, Georgalas I, Georgiadou E, Moschos M, and Thanos S. (2005). Multifocal electroretinography changes in the macula at high altitude: A report of three cases. Ophthalmologica 219:404-412. (Pubitemid 41628306)
43. Quigley HA and Broman AT. (2006). The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90:262-267. (Pubitemid 43325451)
44. Reme CE. (2000). [Photoreceptor renewal and the pigment epithelium of the retina-Congratulations to a pioneer in retinal research: Richard W. Young]. Klin Monbl Augenheilkd 216:129-132. (Pubitemid 30210494)
45. Rex TS, Allocca M, Domenici L, Surace EM, Maguire AM, Lyubarsky A, Cellerino A, Bennett J, and Auricchio A. (2004). Systemic but not intraocular Epo gene transfer protects the retina from light-and genetic-induced degeneration. Mol Ther 10:855-861. (Pubitemid 39419912)
46. Rex TS, Wong Y, Kodali K, and Merry S. (2009). Neuroprotection of photoreceptors by direct delivery of erythropoietin to the retina of the retinal degeneration slow mouse. Exp Eye Res 89:735-740.
47. Roth S, Li B, Rosenbaum PS, Gupta H, Goldstein IM, Maxwell KM, and Gidday JM. (1998). Preconditioning provides complete protection against retinal ischemic injury in rats. Invest Ophthalmol Vis Sci 39:777-785. (Pubitemid 28207473)
48. Safvati A, Cole N, Hume E, and Willcox M. (2009). Mediators of neovascularization and the hypoxic cornea. Curr Eye Res 34:501-514.
49. Sandercoe TM, Geller SF, Hendrickson AE, Stone J, and Provis JM. (2003). VEGF expression by ganglion cells in central retina before formation of the foveal depression in monkey retina: Evidence of developmental hypoxia. J Comp Neurol 462: 42-54. (Pubitemid 36693565)
50. Sapieha P, Sirinyan M, Hamel D, Zaniolo K, Joyal JS, Cho JH, Honore JC, Kermorvant-Duchemin E, Varma DR, Tremblay S, Leduc M, Rihakova L, Hardy P, Klein WH, Mu X, Mamer O, Lachapelle P, Di Polo A, Beausejour C, Andelfinger G, Mitchell G, Sennlaub F, and Chemtob S. (2008). The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis. Nat Med 14:1067-1076.
51. Sargiannidou I, Zhou J, and Tuszynski GP. (2001). The role of thrombospondin-1 in tumor progression. Exp Biol Med (Maywood) 226:726-733. (Pubitemid 32785967)
52. Schlingemann RO. (2004). Role of growth factors and the wound healing response in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 242:91-101. (Pubitemid 38208289)
53. Schodel J, Oikonomopoulos S, Ragoussis J, Pugh CW, Ratcliffe PJ, and Mole DR. (2011). High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq. Blood 117:e207-217.
54. Sheridan CM, Pate S, Hiscott P, Wong D, Pattwell DM, and Kent D. (2009). Expression of hypoxia-inducible factor-1alpha and - 2alpha in human choroidal neovascular membranes. Graefes Arch Clin Exp Ophthalmol 247:1361-1367.
55. Simo R, Carrasco E, Garcia-Ramirez M, and Hernandez C. (2006). Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy. Curr Diabetes Rev 2:71-98. (Pubitemid 44082952)
56. Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, and D'Amore PA. (1994). Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35:101-111. (Pubitemid 24046832)
57. Spranger J, Hammes HP, Preissner KT, Schatz H, and Pfeiffer AF. (2000). Release of the angiogenesis inhibitor angiostatin in patients with proliferative diabetic retinopathy: Association with retinal photocoagulation. Diabetologia 43:1404-1407.
58. Spranger J, Meyer-Schwickerath R, Klein M, Schatz H, and Pfeiffer A. (1999). Deficient activation and different expression of transforming growth factor-beta isoforms in active proliferative diabetic retinopathy and neovascular eye disease. Exp Clin Endocrinol Diabetes 107:21-28. (Pubitemid 29082063)
59. Stahl A, Agostini H, Jandeck C, and Lagreze W. (2011). [Pharmacological treatment for retinopathy of prematurity]. Ophthalmologe 108:777-785.
60. Stone J, Itin A, Alon T, Pe'er J, Gnessin H, Chan-Ling T, and Keshet E. (1995). Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci 15:4738-4747.
61. Stowell C, Wang L, Arbogast B, Lan JQ, Cioffi GA, Burgoyne CF, and Zhou A. (2010). Retinal proteomic changes under different ischemic conditions. Implication of an epigenetic regulatory mechanism. Int J Physiol Pathophysiol Pharmacol 2:148-160.
62. Sullivan T, Kodali K, Rex TS. (2011). Systemic gene delivery protects the photoreceptors in the retinal degeneration slow mouse. Neurochem Res 36:613-618.
63. Terman A and Brunk UT. (2004). Lipofuscin. Int J Biochem Cell Biol 36:1400-1404. (Pubitemid 38625820)
64. Tezel G and Wax MB. (2004). Hypoxia-inducible factor 1alpha in the glaucomatous retina and optic nerve head. Arch Ophthalmol 122:1348-1356. (Pubitemid 39180857)
65. Thiersch M, Lange C, Joly S, Heynen S, Le YZ, Samardzijan, and Grimm C. (2009). Retinal neuroprotection by hypoxic preconditioning is independent of hypoxia-inducible factor-1 alpha expression in photoreceptors. Eur J Neurosci 29:2291-2302.
66. Thiersch M, Raffelsberger W, Frigg R, Samardzija M, Wenzel A, Poch O, and Grimm C. (2008). Analysis of the retinal gene expression profile after hypoxic preconditioning identifies candidate genes for neuroprotection. BMC Genomics 9:73.
67. Watanabe D, Suzuma K, Matsui S, Kurimoto M, Kiryu J, Kita M, Suzuma I, Ohashi H, Ojima T, Murakami T, Kobayashi T, Masuda S, Nagao M, Yoshimura N, and Takagi H. (2005). Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N Engl J Med 353:782-792. (Pubitemid 41215487)
68. West H, Richardson WD, and Fruttiger M. (2005). Stabilization of the retinal vascular network by reciprocal feedback between blood vessels and astrocytes. Development 132:1855-1862. (Pubitemid 40691775)
69. Wiedman M. (1975). High altitude retinal hemorrhage. Arch Ophthalmol 93:401-403.
70. Willmann G, Fischer MD, Schatz A, Schommer K, Messias A, Zrenner E, Bartz-Schmidt KU, and Gekeler F. (2011). Quantification of optic disc edema during exposure to high altitude shows no correlation to acute mountain sickness. PLoS One 6:e27022.
71. Willmann G, Ivanov IV, Fischer MD, Lahiri S, Pokharel RK, Werner A, and Khurana TS. (2010). Effects on colour discrimination during long term exposure to high altitudes on Mt Everest. Br J Ophthalmol 94:1393-1397.
72. Witmer AN, Vrensen GF, Van Noorden CJ, and Schlingemann RO. (2003). Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res 22:1-29. (Pubitemid 36207453)
73. Wong CG, Rich KA, Liaw LH, Hsu HT, and Berns MW. (2001). Intravitreal VEGF and bFGF produce florid retinal neovascularization and hemorrhage in the rabbit. Curr Eye Res 22: 140-147. (Pubitemid 32885407)
74. Yoshida T, Zhang H, Iwase T, Shen J, Semenza GL, and Campochiaro PA. (2010). Digoxin inhibits retinal ischemia-induced HIF-1alpha expression and ocular neovascularization. FASEB J 24:1759-1767.
75. Zhang C, Wang YS, Wu H, Zhang ZX, Cai Y, Hou HY, Zhao W, Yang XM, and Ma JX. (2010). Inhibitory efficacy of hypoxiainducible factor 1alpha short hairpin RNA plasmid DNAloaded poly (D, L-lactide-co-glycolide) nanoparticles on choroidal neovascularization in a laser-induced rat model. Gene Ther 17:338-351.
76. Zhang P, Wang Y, Hui Y, Hu D, Wang H, Zhou J, and Du H. (2007). Inhibition of VEGF expression by targeting HIF-1 alpha with small interference RNA in human RPE cells. Ophthalmologica 221:411-417. (Pubitemid 47608868)